Now in its fourth year, Pharma Sustainability Integrates brings together experts, leaders, academics and policy makers from across industry and healthcare to discuss the challenges and opportunities related to reducing the environmental impact of the industry and the wider healthcare system. Featuring keynote presentations, fireside chats and interactive debate-led panel sessions, the agenda will cover policy, strategy, innovation and how industry can play its part in reducing its own Carbon footprint and that of the wider healthcare eco-system.
This year we will discuss:
Aligning long-term environmental goals with cutting-edge innovations like AI and automation to benefit patients and pharma operations.
How to deliver both environmental and business value at every stage of development, manufacturing, and distribution – from circular economy principles to industry partnerships.
The role of sustainability data in driving decarbonisation and reporting – how do you make it work for you?
PwC UK
Partner, UK Pharma & Life Sciences Leader
Strategy& Deals and Valuations Partner, PwC United Kingdom
With over 20 years’ experience at PwC as a valuation and strategy consultant, Stephen brings experience of working with leading pharma and life sciences businesses in the UK and globally.
As UK Pharma and Life Sciences leader, he is at the forefront of PwC’s support for the industry, leading discussions with business leaders, innovative emerging companies and investors across the various sub-sectors.
Stephen helps companies at a global and local level understand and assess the value of their businesses and assets, the implications of potential strategic options and the opportunities for value creation and growth. His deep commercial, technical and scientific insights help clients to identify the value drivers across a broad base of areas including, drug products, consumer healthcare, pharma services, diagnostics and devices, and innovative biotech.
The industry has been at the forefront of the global pandemic response. Stephen has been supporting companies as they navigate the challenges and demands of this highly uncertain global phenomenon; from understanding how to value companies in times of volatility, as well as considering the appropriate strategic options in the face of an unpredictable business environment.
PwC UK
Partner, ESG Reporting and Assurance
Laura is a Director in ESG Reporting and Assurance PwC who is passionate about the transformational power of an organisation ( whether private or public) focused on broader societal value creation and supporting clients to navigate the complex ESG reporting journey both now and in the future.
She has experience in ESG reporting, assurance, governance risk and controls including the development of reporting frameworks over complex subject matters and building an assurance map against key ESG risks. She works across the FTSE 350, private business, International Development Sector and Central Government and has experience of green bonds, social bonds and innovative funding models in sustainable finance.
Prior to her experience at PwC she has hands on on the ground experience building and running a variety of climate change adaptation and mitigation funds across East, Southern and West Africa including the Africa Enterprise Challenge Fund and the Strategic Climate Institutions Programme in Ethiopia.
Her experience includes TCFD, EU Taxonomy, SASB, GRI, ICMA Green Bond Principles, IFC OPIM Principles.
The Scar Free Foundation & Uplift360
Chief Executive & Chair
General Richard Nugee was commissioned into the British Army in 1986. He completed numerous operational tours and also specialised in personnel (HR) roles both for the Army and Defence culminating in Chief of Defence People (equivalent to Global HR Director for Defence).
As his final role he wrote a Review of Defence’s approach to Climate Change and Sustainability. He has since earned international recognition for bringing the implications of Climate Change and Sustainability to Defence and National Security sectors and has expanded this policy interest into delivery as the Chair, Director and Advisor of a number of renewable energy and environmental sustainability organisations.
He is Chief Executive of the Scar Free Foundation, Chair of the Royal NAAFI Board, a strategic advisor to consultancies and organisations, a Fellow of the Royal Geographical Society and is Patron, Chair and Trustee of a number of organisations such as Invictus Games UK2027.
Lazard
Deputy Chairman UK and Global Senior Advisor
Lord Prior is Deputy Chairman UK and Global Senior Advisor at Lazard.
He is also Chair of Science Capital Imperial, a venture fund aligned with Imperial College and the Institute for Cancer Research, Chair of the Cambridge Life Sciences Council and a member of the Novo Nordisk Sustainability Advisory Council.
He was educated at Cambridge University and subsequently qualified as a barrister. He trained in finance at Lehman Brothers and Lazard Freres in New York before holding a number of senior positions within the industrial sector, including British Steel, where he was Commercial Director. He was elected MP for North Norfolk in 1997 and became CEO and Deputy Chair of the Conservative Party.
He served as Chair of Norfolk and Norwich University Hospitals NHS Foundation Trust from 2002 – 2012 before becoming Chair of the Care Quality Commission. In 2015, he was appointed Parliamentary Under Secretary of State for Health and created a Life Peer. In December 2016, he was appointed as Parliamentary Under Secretary of State at the Department of Business, Energy & Industrial Strategy, with specific responsibility for developing industrial strategy. He stepped down from this role in October 2017 to become Chair of University College London Hospitals and subsequently became Chair of NHS England, a Director of Genomics England and a member of the UK Life Sciences Council to March 2022. He was also Chair of Protas until December 2024.
What does it take to align cutting-edge innovation with long-term environmental goals? This conversation brings together leaders at the intersections of automation, AI and sustainability to examine the risks, responsibilities, and opportunities in leveraging emerging technologies to benefit the industry and ultimately patients too.
GSK
Head of Sustainability & Ecodesign, Medicine Development & Industrialisation
Experienced Vice President with a demonstrated history of working in the pharmaceuticals industry. Strong research, industrialisation and operational professional, skilled in the global leadership of Technical Transfer, Verification and Validation (V&V), Change Control, CMC, GMP, Product Lifecycle Management and Commercial Manufacturing. Responsibilities include, API (Internal & External), Secondary Antibiotic manufacture (Sterile, Oral Solid Dose, Sachets and Suspensions), Materials Science, Biological and Genetic Engineering, Chemical Synthesis, Process & Cleaning Validation and Data & Informatics.
IntelligenceQ
Co-founder & CEO
At IntelligenceQ, I am committed to advancing the future of sustainable medicine manufacturing through AI-driven solutions. Our platform, GyaniMed™ is designed to integrate and simplify complex scientific data across research, process design, and validation, breaking down traditional barriers in medicine manufacturing.
We believe AI is not magic—it is a powerful tool that, when deployed at the right stages, can transform efficiency and collaboration in medicine development. Through real-time AI and Scientist-in-the-Loop technology, GyaniMed™ enables operational and innovation efficiency, providing scientists with sophisticated yet accessible tools to make a meaningful impact. Our goal is to optimise drug manufacturing timelines, enhance sustainability, and empower scientists to bring effective treatments to patients faster.
I am passionate about ensuring that cutting-edge AI technology meets the needs of pharmaceutical scientists and manufacturers by creating accessible, integrated, and cost-friendly solutions that foster collaboration and drive positive change.
PwC UK
Director, Sustainability, Strategy& UK
Paisley is a sustainability and strategy consultant specialising in the intersection of sustainability and digital transformation. She has worked with leading companies to use data, technology and innovation to accelerate decarbonisation and identify, measure and manage their impacts and dependencies on nature. Her experience spans supporting companies with their net zero transition, advising on emerging nature-related frameworks, guiding organisations on biodiversity and ecosystem considerations, and developing holistic sustainability strategies and measurement approaches. Passionate about practical solutions, Paisley brings both technical insight and strategic perspective to advance corporate action on nature and climate.
Decarbonising supply chains demands deep collaboration, especially in pharma where sustainability now drives KPIs, compliance, risk, and long-term value. From green formulation and packaging to energy-efficient facilities, sustainability is no longer a side project – it’s a competitive differentiator. And in areas such as respiratory care, the opportunity to align clinical outcomes with environmental responsibility is particularly strong. How can companies design environmental responsibility into every stage of development, manufacturing, and distribution?
DHL Supply Chain UKI
VP Business Development & Account Management, Life Sciences & Healthcare
Richard Dunn is a seasoned logistics professional with over 24 years of experience in the supply chain industry and further into Life Sciences and healthcare within the supply chain. Throughout his career, he has demonstrated an unwavering drive for progress and a strong commitment to helping customers and colleagues succeed. Richard’s expertise lies in transforming supply chains through strategic partnerships and innovative solutions.
Richard has been instrumental in the development and deployment of global supply chain solutions for both new and existing customers. His deep understanding of sales strategy and his passion for continuous improvement have led to the successful implementation of innovative approaches that deliver enhanced value to customers.
In addition to his accomplishments in supply chain management, Richard has also been actively involved in the development of sales and account management processes. He has played a key role in the creation of digital tools and resources that have streamlined operations and enhanced overall customer experience.
Speaker tbc
Speaker TBC
Can pharma move beyond transactional approaches to sustainability and embrace deeper, innovation-focused partnerships? This session explores how the industry can rethink engagement – shifting from compliance to collaboration – and what it can learn from other sectors that are leading the way in sustainable innovation.
Innovate UK
Innovation Lead
Hareklea (Hari) Markides is Innovation Lead in the Future Medicines – Medicines Manufacturing team at Innovate UK. In her role, she supports innovative businesses through grant funding and collaborative opportunities, helping to strengthen the UK’s medicines manufacturing capability and drive innovation across the life sciences sector.
RoslinCT
Head of Sustainability
Adam started his professional career as a chemist, later diversifying into environmental protection focusing on waste management, producer responsibility, and transfrontier shipments of waste. Adam then spent 10 years in consultancy, advising private and public sector clients on strategic and technical application of resource efficiency and the circular economy, before developing and leading corporate sustainability strategies focused on delivering real impact for people and the planet. Adam is an alumnus of the University of Edinburgh and an active member of numerous local, national and global sustainability working groups. He has presented at various conferences and events including COP26, providing global representation for his employers. Adam is a Chartered Waste Manager and accredited Project Manager, a keen cyclist, a father of two boys, and lives in Portobello in Edinburgh.
UCL & Real Zero
Professor Intensive Care Medicine & Co-founder
Intensive Care clinician. Director UCL Centre for Human Health and Performance, with >550 papers (8 in Nature, inc first description of a ‘gene for human performance’.)
Extensive work in Climate Change. Founder https://realzero.earth/
Consults in medtech (inc previously for Google Health/ Deepmind) and pharma (lately vaccines).
Board, Silver Creek Ltd
ex-Board Chair ed-tech: Obrizum https://www.obrizum.com/
5 charity boards
22 years leader in health and climate change (chair 27-country Lancet Countdown)
Founder and Board, ‘Real Zero Ltd’ (non-profit action on climate change)
Award winning author (2 x childrens’ books, 1 x thriller) and script editor.
Public speaker (>600 invited lectures to public, business, medicine and science) fronting >6 TV shows, inc 5 Royal Institution Xmas Lectures 2007)- https://londonspeakerbureau.com/speaker-profile/hugh-montgomery/
AstraZeneca
Global Medical Affairs Leader, Respiratory Sustainability
Ekaterina is Global Medical Affairs Leader, Respiratory Sustainability at AstraZeneca, where she is responsible for evidence strategy and delivery for part of the respiratory portfolio. Ekaterina trained as an epidemiologist at Harvard School of Public Health and has over 15 years of experience in epidemiological research and public health across academia, government, and industry. For the past 4 years, Ekaterina has lead evidence generation on the environmental impact of asthma care pathways as part of the CARBON program and supporting wider capability build initiatives across AstraZeneca. More recently, she has co-led the development of CARESA, a modelling tool to quantify the environmental impact of care pathways. Ekaterina is interested in how care delivery impacts environmental sustainability, and how we (re)-design healthcare systems for the future that deliver for the patients and the planet.
University of Oxford
British Academy Global Professor
Paul’s research focusses on the implications of rapid food system transformations in a rapidly changing world.
There is an urgent need for a Great Food Transformation to reduce environmental harm and to increase food system resilience. Paul is working on integrated models to assess the environmental and social impacts of such a transition on both consumers and producers. His research program explores the social outcomes of this transformation—from changes in subsidies and land management to increasing food security.
Paul is the author of the popular science book, The Best of Times, The Worst of Times: Futures from the Frontiers of Climate Science (Indigo Press, 2021) which describes humanity’s current trajectory and possible futures in paired chapters of pessimism and hope. His research and writing on climate, energy, and food, has appeared in scientific journals and media outlets such as the BBC, The Guardian, Thomson Reuters, Politico, Nature Sustainability, Nature Energy, PNAS, Nature Food, and Nature Communications. He is an editor and author of the interdisciplinary textbook Food and Sustainability (Oxford University Press, 2020). Paul won International Champion in the Frontiers Planet Prize in 2023.
As sustainability data becomes more complex, pharma and policy leaders face a new challenge to turn carbon metrics into actionable, impactful decisions. How do we cut through the noise, use data wisely, and apply the right metrics to drive real-world decarbonisation across operations and supply chains and as a basis for reporting?
Sustainable Healthcare Coalition
Chair
As a leading expert in sustainability and health, I currently serve as Chair of the Sustainable Healthcare Coalition a pioneering organisation that brings together partners to advance sustainable healthcare.
Additionally, I act as an independent expert advisor and board member for various national and global organisations, providing valuable insight and guidance on well-being and sustainability.
I’m passionate about reframing thinking and have a track record of developing innovative strategies and programmes at the heart of business and government.
My background includes senior roles in the UK Government as Deputy Chief Medical Officer and Director General, in the World Health Organisation as Director of Chronic Disease and Health Promotion, and in the private sector, as Bupa’s Chief Wellbeing Officer and as a Director in PwC’s health and sustainability teams.
I am a visiting Professor at UCL and a Senior Associate at Cambridge Institute for Sustainability Leadership and have served on various boards including British Land’s Sustainability Advisory Panel, Marks and Spencer’s Sustainable Retail Advisory Board, and Business in the Community’s Wellbeing Leadership Team.
Medicines and Healthcare products Regulatory Agency (MHRA)
Head of Standards and Regulatory Governance, Secretary, Scientific Director of the BP Commission
Steve Hoare is responsible for the British Pharmacopoeia, which sets the minimum standards for Quality for medicines marketed in the UK (and recognised in over 100 countries) , and is supporting the MHRA in the development of its Sustainability Policy. An analytical chemist by training, Steve has a background in Quality roles in the pharmaceutical industry, most recently a policy director for a biopharmaceutical trade association, leading on both regulation and sustainability. Steve is active in the development of international approaches to sustainability in standards setting.
Bayer
Head of Sustainability & Public Affairs UK & Ireland
Andy spent 17 years in senior Sales leadership and Commercial roles within FMCG, Skincare and Pharma, he then made a career pivot over 3 years ago to proactively supercharge and lead the Sustainability agenda at Bayer UK & Ireland. Andy works across the full spectrum of Sustainability, covering Policy, ESG & Non-Financial Disclosures, Carbon Footprinting, Impact Valuation, Life Cycle Assessments, Employee Engagement and many more.
Andy voices how driving a culture of sustainability and incorporating it into everyday roles and responsibilities is essential to delivering a net zero agenda as well as the powerful role story telling plays in supporting organisations transformation from Board level all the way through the business.
GSK
Director, Global Sustainability Policy
Rachel leads GSK’s global approach to environmental sustainability policy, supporting the company’s ambition for a net zero, nature positive, healthier planet. Rachel has worked in policy and government affairs roles across the pharmaceutical sector for over 10 years, and has previously worked on environmental policy, including in the European parliament and in the water sector.
Digital Technologies Group (DTG)
Head of Sustainability
John is a Manufacturing and Sustainability Consultant, and Head of Sustainability of the Digital Technologies Group (DTG). Prior to this, John was the Director of the Medicines Manufacturing Innovation Centre, Glasgow, a collaboration between CPI, University of Strathclyde, UK Research & Industry, Scottish Enterprise and founding industry partners, AstraZeneca and GSK.
The center’s principle goal is to accelerate the adoption of innovative technology and techniques in pharmaceutical manufacturing, with a mission to make the next generation of medicines available, affordable and without impacting the planet. MMICs strategic focus is on oligonucleotides, continuous manufacturing, digital and date.
Prior to joining CPI in October 2019 John worked for GSK, joining the company in 1986 as a Process Chemist at the Worthing Site. During his time on Site he held roles covering all aspects of the manufacturing supply chain from large scale fermentation, fine chemicals (both chemical and enzymatic conversions), Chemical Development and Secondary Sterile Operations.
After 10 years of site base roles he was seconded to Head office to lead a workstream of a global supply restructuring programme. In 2000 he moved to the Irvine plant to lead the Development team and take change of the construction a new 300te nanomilling and spray drying plant. This period was followed with a number of roles working out of GSK House in strategic program leadership including Head of the Global Manufacturing & Supply Programme Management Office, 5 years in the Core Business Services Function (IT, Procurement and Real estate) as Head of PMO and finally back to manufacturing to Leader a Global manufacturing restructuring programme.
John has a BSc (Hons) in Chemistry, an MBA from Strathclyde University Business School, a Private Pilot’s license and double decker bus license.
NHS England
Head of Net Zero Delivery and Partnerships, Greener NHS
Sarah Ouanhnon is Head of Net Zero Delivery and Partnerships, Greener NHS Programme at NHS England . Sarah works in partnership with the WHO and other healthcare systems to decarbonise healthcare and healthcare supply chains, building on the delivery of the NHS net zero commitments across Medicines, Supply Chain and Food, within the Greener NHS team. Her recent work includes the implementation of the first incentive scheme to encourage more sustainable practice for inhaler prescribing, and the publication of the NHS Supplier Roadmap, outlining requirements of NHS suppliers for the next ten years. Sarah has 10 years of experience in managing large-scale change programmes in primary, acute and community care, as well as across systems.
The promise of circularity is clear, but how can pharma make it a powerful driver of transformation and growth? Panellists will discuss practical strategies to embed circular economy principles across pharma operations, reduce waste, and create sustainable, regenerative systems that deliver long-term environmental and business benefits – while still keeping the patient front of mind.
Sartorius
Sustainability Marketing Expert
Lara Cobacho Lluesma has been working for Sartorius since 2022, where she currently serves as Sustainability Marketing Expert. She holds a Master’s degree in Life Science Economy and Policy with a focus on sustainability from the Technical University of Munich.
She initially joined Sartorius as a Sustainability Project Manager, leading strategic partnerships and acting as the key liaison for sustainability initiatives with major biopharma customers. In 2024, she transitioned into her current role, where she drives strategic marketing communications and industry advocacy for sustainable bioprocessing. Her work emphasizes the importance of advancing the sustainability of Single-Use Technologies (SUTs), which are increasingly recognized in biomanufacturing not only for their operational benefits, but also for their potential to reduce environmental impact. Her work focuses on initiatives that enhance process efficiency, promote circularity, and facilitate industry collaboration. These efforts are recognized as crucial to leverage the environmental advantages of SUTs within the biopharma industry.
Fujifilm Biotechnologies
Head of Global Sustainability, Fujifilm Diosynth Biotechnologies
Director of sustainability in international companies with experience in improving company profiles on Sustainability. Experience in Sustainability Strategy, SBTi target setting, CSRD Reporting, ISO 14001 & 45001 certifications, CDP reporting, stakeholder communication, legislation and change management. I have an educational basis within environmental engineering followed by Graduate Diploma in Strategic management and leadership (HDO) from Copenhagen Business School. Currently working as Head of Sustainability for the FujiFilm Biotechnology a world leading Bio-CDMO and part of FujiFilm Holding. On ad hoc basis external examinator at DTU on bachelor and master programs within Sustainability, Circular Economy and Eco Design
Covestro
Technical Marketing Manager – Healthcare EMEA
Dr. Bernd Garska currently serves as Technical Marketing Manager for healthcare applications across EMEA within Covestro’s Engineering Plastics business entity. He holds a PhD in macromolecular chemistry from Heinrich Heine University Düsseldorf. He began his career in Customer Applications at an SME before joining Covestro in 2015, where he has expanded his expertise through roles in R&D and Production, gaining comprehensive insight into the entire materials value chain. His international experience spans Germany, China, and Belgium.
In his current role, he drives technical marketing strategies that bridge advanced polycarbonate technologies with evolving healthcare needs and sustainability requirements. His work focuses on enabling innovation through high-performance materials solutions that balance functionality with sustainability aspects
London is a diverse, interconnected hub with millions living, working and travelling throughout the city on a daily basis. This includes many of our own clients and people, and the wider business community. As the city’s population grows, challenges including affordable housing, transport and infrastructure improvements and upskilling require increased attention. We see it as our priority to help find the right solutions for London.
After almost two years of refurbishment, in 2014 we fully reopened our Embankment Place office in London, achieving the highest ever score under BREEAM, the world’s foremost environmental assessment method and rating system for buildings.
Address: PricewaterhouseCoopers LLP, 1 Embankment Place, London, WC2N 6RH
Tel: +44 (0)20 7583 5000
